Astegolimab
Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.
Product Specifications
CAS Number
2173054-79-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Interleukin
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1139639-01 0.02 mg (E-Coli)
Recombinant Salmonella agona Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD)
Ask
View Details 
MBS1139639-02 0.02 mg (Yeast)
Recombinant Salmonella agona Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD)
Ask
View Details MBS1139639-03 0.1 mg (E-Coli)
Recombinant Salmonella agona Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD)
Ask
View Details MBS1139639-04 0.1 mg (Yeast)
Recombinant Salmonella agona Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD)
Ask
View Details 
MBS1139639-05 0.02 mg (Baculovirus)
Recombinant Salmonella agona Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD)
Ask
View Details MBS1139639-06 0.02 mg (Mammalian-Cell)
Recombinant Salmonella agona Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD)
Ask
View Details